Get in touch
Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.
NEO AML Express
- Next Generation Sequencing (NGS)
The NEO | AML Express assay is a next-generation sequencing (NGS) assay using combined DNA- and RNA-sequencing, which is used to identify prognostically and diagnostically informative alterations in acute myeloid leukemia (AML). The DNA sequencing component of this assay detects single nucleotide variants (SNVs) and indels in genes recurrently mutated in AML, and the RNA sequencing component detects fusions involving genes that are frequently involved in structural rearrangements observed in AML, as noted below. Test reports include a summary interpretation of all results together.
DNA (38 genes): ABL1, ASXL1, BCOR, BRAF, CALR, CBL, CEBPA, CSF3R, DDX41, DNMT3A, ETV6, EZH2, FLT3 (ITD and TKD), GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NF1, NPM1, NRAS, PHF6, PPM1D, PRPF8, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2
RNA (9 genes): ABL1, KAT6A, KMT2A, MECOM, MYH11, NUP214, NUP98, RARA, RUNX1
Turnaround time
5 Days
Level of Service
- Global
New York Approved: No
Specimen Requirements
Peripheral Blood: 2mL to 3mL in EDTA Tube. Bone Marrow Aspirate: 1mL to 2mL in EDTA Tube.
Storage and Transportation
Storage & Transportation: Use cold pack for transport, making sure cold pack is not in direct contact with specimen. Important! To ensure fast TAT and sample stability, ship samples directly to NeoGenomics Houston.
CPT Code(s)*
Client-Bill Only
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.
Last Updated: February 12, 2025